バイオコモ Company Profile

A drug discovery venture engaged in the research and development of a new vaccine.

Biocomo Co., Ltd. is a drug discovery venture company that is working on the research and development of a new vaccine in collaboration with Professor Tetsuya Nosaka from the Graduate School of Medicine at Mie University, specializing in Infectious Disease Control Medicine and Molecular Genetics. Biocomo has successfully developed a new vaccine vector with different characteristics from existing vaccines in collaboration with the Nosaka laboratory. The aim is to create a vaccine that retains the high immune-inducing ability of live vaccines while eliminating the risk of infectious disease associated with live vaccines, and that can efficiently introduce large-sized protein/peptide antigens, which has been difficult with conventional vaccine technologies. To achieve these two characteristics, we are focusing on hPIV2 and engaging in research and development.